Table 2.
World Health Organization (WHO) grading and IDH1 (isocitrate dehydrogenase 1 (NADP(+)) status of patients.
| Patient Number | Astrocytoma WHO Grade | IDH1 |
|---|---|---|
| 1 | II | IDH1 (R132H) mutation (IDH1+) |
| 2 | II | IDH1 R132H) mutation (IDH1+) |
| 3 | II | IDH1 (R132H) mutation (IDH1+) |
| 4 | II | IDH1 (R132H) mutation (IDH1+) |
| 5 | II | IDH1 (R132H) mutation (IDH1+) |
| 6 | II | IDH1 (R132H) mutation (IDH1+) |
| 7 | III | IDH1 (R132H) mutation (IDH1+) |
| 8 | III | IDH1 (R132H) mutation (IDH1+) |
| 9 | III | IDH1 (R132H) mutation (IDH1+) |
| 10 | III | IDH1 (R132H) mutation (IDH1+) |
| 11 | III | IDH1 (R132H) mutation (IDH1+) |
| 12 | IV | IDH1 wildtype (IDH1−) |
| 13 | IV | IDH1 wildtype (IDH1−) |
| 14 | IV | IDH1 wildtype (IDH1−) |
| 15 | IV | IDH1 wildtype (IDH1−) |
| 16 | IV | IDH1 wildtype (IDH1−) |
| 17 | IV | IDH1 wildtype (IDH1−) |
| 18 | IV | IDH1 wildtype (IDH1−) |
| 19 | IV | IDH1 wildtype (IDH1−) |
| 20 | IV | IDH1 wildtype (IDH1−) |
| 21 | IV | IDH1 wildtype (IDH1−) |
| 22 | IV | IDH1 wildtype (IDH1−) |